BIOmarkers Before and After Kidney Transplantation
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Jan 30, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "BIOmarkers Before and After Kidney Transplantation," is focused on understanding how certain markers in urine, blood, and tissue can help doctors diagnose and manage kidney diseases. These markers, known as biomarkers, can provide valuable information about the condition of the kidneys, especially in patients who are about to undergo a kidney transplant or have had a kidney biopsy. The goal of the study is to see how these biomarkers can improve the treatment and monitoring of kidney disease in patients.
To participate in this trial, individuals should be over 18 years old and currently hospitalized for either a kidney biopsy or a kidney transplant. Participants must also be able to provide informed consent and have social security coverage. However, those who are pregnant, breastfeeding, under legal protection, or unable to give consent are not eligible. If you join the study, you can expect to contribute to important research that could help enhance kidney disease management for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient hospitalised for renal biopsy of a native kidney or for renal transplantation
- • Age \>18 years
- • Informed and consented
- • Covered by a social security scheme
- Exclusion criteria:
- • Patients under guardianship, conservatorship or legal protection
- • Pregnant or breastfeeding
- • Patient deprived of liberty
- • Patients of legal age who are unable to give consent
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Créteil, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported